Community/Retail

Top news of the day from across the health care landscape.

Advancements in the understanding of asthma pathophysiology has led to the discovery of defined asthma phenotypes and targeted interventions involving novel biologic therapies.

Although the levels of NDMA that was found through FDA testing are much lower than the levels that a few third-party investigators claimed, the report indicated that these levels exceed what the FDA considers acceptable for these medicines.

A recent study demonstrated that budesonide-formoterol is superior to albuterol for as-needed exacerbation prevention in mild asthma.

Labeling, seals of approval, and ingredients should be considered when counseling patients about dietary supplements.

Texas oncologist Stephen Hahn, MD, is expected to receive the Trump administration’s nomination for the role of FDA Commissioner, a move that had been anticipated by federal insiders.

The Ensuring Seniors Access to Local Pharmacies Act, which was recently reintroduced, would allow more “preferred” pharmacies in medically underserved areas.

The FDA Drug Shortages Task Force addressed the root causes of drug shortages and proposed potential solutions.

Kala Shankle, JD, and Lisa Schwartz, PharmD, RPh, discuss the DSCSA and what it means for pharmacists. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

The injection’s active ingredient, 17α hydroxyprogesterone caproate (also known as 17P), is currently the only approved treatment for pregnant women who have had a prior spontaneous preterm birth.

Multiple health care organizations, including The American Hospital Association (AHA), the Institute for Safe Medication Practices (ISMP), and the American Society of Health-System Pharmacists (ASHP), have shown their full support for the MEDS Act.

Care planning can increase pharmacy profits through efficiencies and through new revenue from payers that value what pharmacists do for patients, if they see the documentation of what has been done.

Karla Palmer, director at Hyman, Phelps, & McNamara, discusses how the Hemp Farming Act of 2018 affected hemp and CBD products.

What is causing this patient to lose her sense of smell?

Two experts shared best practices for operating a pharmacy convenience packaging service with attendees of the National Community Pharmacists Association (NCPA) 2019 Annual Convention in San Diego, California, on Sunday, October 27.

Making medication synchronization a core tenet of a pharmacy’s business can lead to success.

With the legalization of CBD products in 2018, many questions have emerged, not only on the laws governing these products, but on how to integrate CBD into community pharmacies.

Attendees of a session on operating a long-term-care (LTC) pharmacy received tips on key metrics, technology advancements, and meeting customer needs, during the National Community Pharmacists Association (NCPA) 2019 Annual Convention.

Utilizing many of the skills learned in pharmacy school could help to personalize care and enhance medication delivery for patients, potentially leading to reductions in adverse drug events and health care costs,

Pharmacy Times® and Parata Systems celebrated the winners of the 2019 Next-Generation Pharmacist® Awards yesterday at a ceremony held concurrently with the 2019 NCPA Annual Meeting in San Diego, California.

Officials with the FDA have expanded the use of Melinta Therapeutics’ delafloxacin (Baxdela) to include treatment of adult patients with community-acquired bacterial pneumonia caused by designated susceptible bacteria, but the drug’s availability will be delayed for this new indication.

Researchers have found that patients with high blood pressure (BP) who take all their antihypertensive medications at bedtime have better controlled blood pressure and a significantly lower risk of death or illness caused by heart or blood vessel problems, compared to patients who take their medications in the morning.1

Top news of the day from across the health care landscape.

Effective December 31, 2019, Amgen’s 60% annual list price cut for evolocumab (Repatha) will be fully implemented.

Officials with the FDA have approved Allergan’s supplemental Biologics License Application (sBLA) for onabotulinumtoxinA (BOTOX®) to expand its indication to include treatment of pediatric patients, ages 2 to 17 years, with lower limb spasticity, excluding spasticity caused by cerebral palsy.

The influenza A virus remains contagious in wet mucus from infected patients, even after being exposed to an ethanol-based disinfectant.

McKesson’s Health Mart has announced a partnership with Amazon Hub Counter pickup points, offering customers more convenient delivery options.

Top news of the day from across the health care landscape.

One in 8 pharmacies closed from 2009 to 2015, despite an overall increase in the number of pharmacies during this time.

Top news of the day from across the health care landscape.